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non-malignant pain
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Abstract
Background: Despite recent guidelines suggesting that patients with chronic non-malignant pain might not benefit,
there has been a significant rise in opioid prescription for chronic non-malignant pain. This topic is important because
an increasing number of HCPs are prescribing opioids despite very limited evidence for long-term opioid therapy for
chronic non-malignant pain outside of end-of-life care. To better understand the challenges of providing effective
treatment, we conducted the first qualitative evidence synthesis to explore healthcare professionals’ experience of
treating people with chronic non-malignant pain. We report findings that explore healthcare professionals’ experience of
prescribing opioids to this group of patients.
Methods: We searched five electronic bibliographic databases (Medline, Embase, CINAHL, PsychINFO, AMED) from
inception to November 2015 and screened titles, abstracts and full texts of potential studies. We included studies in
English that explored healthcare professionals’ experience of treating adults with chronic non-malignant pain. Two
reviewers quality appraised each paper. We used the methods of meta-ethnography developed and refined for large
reviews, and the GRADE-CERQual framework to rate confidence in review findings.
Results: We screened 954 abstracts and 184 full texts, and included 77 studies in the full review. 17 of these 77 studies
included concepts that explored the experience of prescribing opioids. We abstracted these concepts into 6 overarching
themes: (1) Should I, shouldn’t I? (2) Pain is Pain; (3) Walking a fine line; (4) Social guardianship; (5) Moral boundary work;
(6) Regulations and guidelines. We used the GRADE-CERQual framework to evaluate confidence in findings. A
new overarching concept of ‘ambiguity’ explains the balancing required around the factors taken into account
when prescribing opioids. Managing this ambiguity is challenging and these findings can inform healthcare
professionals dealing with these decisions.
Conclusions: This conceptual model demonstrates the complexity of making a decision to prescribe opioids to
someone with chronic non-malignant pain. Although opioid prescription is underpinned by the therapeutic aim
of alleviating pain, this aim may be misplaced. This has implications for education in light of the new regulations
for opioid prescription. Findings also demonstrate that the decision is influenced by intra- and interpersonal
factors and broader external concerns.
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Background
Population estimates suggest that around 25% of adults
around the world suffer with moderate or severe pain
[1–5] and for between 6 and 14% of these adults pain
can be severe and disabling [5, 6]. Each year over five
million people in the UK develop chronic non-malignant
pain [7], and healthcare professionals (HCPs) can find it
a challenge to effectively treat this pain. For example,
they can find it difficult if they are unable to offer the
patient a solution [8], or if they have to refuse patients’
requests for a particular test or treatment [9, 10]. Despite
recent USA [11] and UK guidelines [12] suggesting that
patients with chronic non-malignant pain might not gain
benefits, opioids are commonly prescribed for uncon-
trolled persistent pain, and there has been a significant rise
in opioid prescription [13–18]. Survey data suggest that
around 12% of UK patients with chronic non-malignant
pain are prescribed strong opioids, mainly by GPs [1]. As
many as 20% of patients with non-malignant pain symp-
toms receive an opioid prescription [19].
In order to better understand the challenges of provid-
ing effective treatment, we aimed to explore healthcare
professionals’ experience of treating patients with chronic
non-malignant pain by conducting a qualitative evidence
synthesis in this area. A full report of HCPs experience of
treating patients with chronic non-malignant pain is being
published by the NIHR Journals library [20]. We aimed to
focus on the experience of treating chronic pain condi-
tions with no clear attributable biomedical cause. Qualita-
tive evidence synthesis aims to systematically search for
and integrate findings in order to increase our under-
standing of complex processes of care, and thus im-
prove the experience and quality of that care. As part of
this review, we found a body of evidence that specifically
explored healthcare professionals’ (HCPs) experience of
prescribing opioid medication to patients with chronic
non-malignant pain. This topic is important because an
increasing number of HCPs are prescribing opioids despite
very limited evidence for long-term opioid therapy for
chronic non-malignant pain outside of end-of-life care [18].
Methods
We used the methods of meta-ethnography developed, re-
fined and reported in a previous qualitative evidence syn-
thesis of patients’ experience of chronic non-malignant
musculoskeletal pain [21]. There are seven stages to meta-
ethnography: getting started, deciding what is relevant,
reading the studies, determining how studies are related,
translating studies into each other, synthesising transla-
tions and expressing the synthesis [22].
Search strategy
We searched five electronic bibliographic databases
(Medline, Embase, CINAHL, PsychINFO, AMED) from
inception to end of November 2015 using terms adapted
from the InterTASC Information Specialists’ Sub-Group
(ISSG) Search Filter Resources [23–26]. We combined
thesaurus terms from each database with free text terms
for qualitative research as a subject, and for pain as a sub-
ject (Table 1). Previous research suggests that citation
checks, hand searching, grey literature or PhD searches do
not necessarily add value to large meta-ethnographies. For
example, Toye and colleagues found that 95% of studies
were identified in the first three databases searched [21,
27]. FT and KLB screened the titles, abstracts and full text
of potential studies for relevance. Any disagreement was
discussed and resolved with a third reviewer.
Inclusion/exclusion criteria
We included studies written in English that explored
HCPS’ experience of treating adults with chronic non-
malignant pain. We used a broad search strategy that in-
cluded ‘PAIN’ as both a thesaurus and free text term in
order to encompass all chronic non-malignant pain con-
ditions. We excluded acute pain, head pain, arthritis (in-
cluding osteoarthritis and rheumatoid arthritis), patient
experience and studies where HCP experience could not
be disentangled from the experience of others. Our focus
was on non-specific chronic non-malignant pain. We
did not include HCPs experience of treating patients
with arthritis as, after consultation with our advisory
group of clinicians and patients, we felt it likely that
treating conditions with bio-medically attributable
causes would be qualitatively different. At the outset of
this study, we had intended to only include HCPs ex-
perience of treating chronic non-malignant musculoskel-
etal pain in order to mirror a previous QES of patients’
experience of chronic non-malignant musculoskeletal
pain [21]. However our preliminary reading indicated
that HCPs experience of treating chronic non-malignant
pain was not boundaried to a particular body system,
but was a summative experience that cuts across
conditions.
Quality appraisal
Although there are many suggested frameworks, there is
no consensus on what makes a qualitative study good [28,
29]. We used three methods of quality appraisal to frame
our discussions regarding inclusion: (a) The Critical Ap-
praisal Skills Programme (CASP) questions for appraising
qualitative research [30]; (b) constructs from a qualitative
study embedded in a previous large meta-ethnography
[31]; (c) a global appraisal of whether the study was: a ‘key
paper’ (‘conceptually rich and could potentially make an
important contribution to the synthesis’); a satisfactory
paper; a paper that is irrelevant to the synthesis; a meth-
odologically fatally flawed paper [29]. Two reviewers ap-
praised each paper, and if they were unable to reach an
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agreement, the study was sent to another reviewer for the
final decision. We utilised the GRADE-CERQual frame-
work [32] which aims to help reviewers to assess and de-
scribe how much confidence readers can place in review
findings. GRADE-CERQual suggest four domains of inter-
est: (1) ‘Methodological limitations’ concern the conduct
of the primary study; (2) ‘Relevance’ is the extent to which
the primary studies are applicable to the review; (3) ‘Ad-
equacy of data’ is an ‘overall determination of the degree
of richness and quantity of data supporting a review find-
ing’; (4) Coherence considers how well the findings are
grounded in the primary studies [32].
Data extraction and synthesis
Two reviewers read each paper to develop a list of the
concepts from the primary papers. If they agreed that
there was no clear concept then it was not included in
the analysis. Translating studies into each other involves
comparing concepts in order to sort them into conceptual
categories [22]. All reviewers sorted the concepts into
categories with shared meaning. Through constantly com-
paring and discussing these categories they started to see
similarities and differences that allowed further abstraction
into the final conceptual categories. The final analytic stage,
‘synthesising translations’ involved integrating the concep-
tual categories into a conceptual framework. We planned
to develop a line of argument synthesis, which involves
‘making a whole into something more than the parts alone
imply’ [22] (page 28). This is achieved by comparing con-
cepts and developing ‘a grounded theory that puts the simi-
larities and differences between studies into interpretive
order’ [22] (page 64).
Results
We report findings that explored HCPs’ experience of pre-
scribing opioids to patients with chronic non-malignant
Table 1 Example search terms – Medline: (a) qualitative subject headings); (b) qualitative free text terms; (c) pain subject headings;
(d) pain free text terms
(I) QUALITATIVE SUBJECT HEADINGS exp QUALITATIVE RESEARCH
exp. INTERVIEWS AS TOPIC
exp. FOCUS GROUPS
NURSING METHODOLOGY RESEARCH
ATTITUDE TO HEALTH
(II) QUALITATIVE FREE TEXT TERMS Qualitative ADJ5 (theor* OR study OR studies OR research OR analysis)
ethno.ti,ab
emic OR etic. ti,ab
phenomenolog*.ti,ab
hermeneutic*.ti,ab
heidegger* OR husserl* OR colaizzi* OR giorgi* OR glaser OR strauss OR (van AND kaam*) OR (van
AND manen) OR ricoeur OR spiegelberg* OR merleau).ti,ab
constant ADJ3 compar*.ti,ab
focus ADJ3 group*.ti,ab
grounded ADJ3 (theor* OR study OR studies OR research OR analysis).ti,ab
narrative ADJ3 analysis.ti,ab
discourse ADJ3 analysis.ti,ab
(lived OR life) ADJ3 experience*.ti,ab
(theoretical OR purposive) ADJ3 sampl*.ti,ab
(field ADJ note*) OR (field ADJ record*) OR fieldnote*.ti,ab
participant* ADJ3 observ*.ti,ab
action ADJ research.ti,ab
(digital ADJ record) OR audiorecord* OR taperecord* OR videorecord* OR videotap*).ti,ab
(cooperative AND inquir*) OR (co AND operative AND inquir*) OR (co-operative AND inquir*)
.ti,ab
(semi-structured OR semistructured OR unstructured OR structured) ADJ3 interview*.ti,ab
(informal OR in-depth OR indepth OR “in depth”) ADJ3 interview*.ti,ab
(“face-to-face” OR “face to face”) ADJ3 interview*.ti,ab
“IPA” OR “interpretative phenomenological analysis”.ti,ab
“appreciative inquiry”.ti,ab
(social AND construct*) OR (postmodern* OR post-structural*) OR (post structural* OR poststructural*)
OR (post modern*) OR post-modern* OR feminis*).ti,ab
humanistic OR existential OR experiential.ti,ab
(III) PAIN SUBJECT HEADINGS exp BACK PAIN/OR exp. CHRONIC PAIN/OR exp. LOW BACK PAIN/OR exp.
MUSCULOSKELETAL PAIN/OR exp. PAIN/OR exp. PAIN CLINICS/.
exp. FIBROMYALGIA/
exp. PAIN MANAGEMENT/
(IV) PAIN FREE TEXT TERMS (chronic* OR persistent* OR long-stand* OR longstand* OR unexplain* OR un-explain*)
fibromyalgia
“back ache” OR back-ache OR backache
“pain clinic” OR pain-clinic*
pain adj5 syndrome*
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pain. A full report of HCPs experience of treating patients
with chronic non-malignant pain is being published by
the NIHR Journals library [20]. The results of the system-
atic search are shown in Fig. 1. We screened 954 poten-
tially relevant studies and excluded 770 after screening the
abstracts. We retrieved 184 full text articles and excluded
101. We excluded 16 studies that were not qualitative or
that included limited qualitative data, and 85 studies that
we agreed were out of scope (for example, they did not
present the HCP voice, or they did not explore the experi-
ence of chronic non-malignant pain). Full details of study
exclusions are being published elsewhere [20]. Of the 83
studies remaining, we unanimously excluded a further six
on the grounds of methodological report. After reading
and extracting concepts from the remaining 77 studies,
the reviewers identified 17 studies that included concepts
specific to the experience of prescribing opioids to pa-
tients with chronic non-malignant pain [33–49]. Table 2
gives the author, year, country, participants, data collec-
tion, analytic method and aim of the 17 studies included.
Findings are drawn from 486 HCPs from different geo-
graphic locations; USA (n = 10), UK (n = 4), Canada (n =
2), Spain (n = 1) (Table 2).
All reviewers discussed and organised the concepts
into 18 conceptual categories. Only a single concept did
not fit into a conceptual categories (Barry 2010: Patient
Factors - Cost of Specialty Pain Management [34]). This
described how some HCPs felt their patients were con-
cerned about the costs and coverage of specialty pain
management and therefore might only be relevant to
healthcare systems that are not free at point of delivery.
All four reviewers further abstracted the 18 conceptual
categories into 6 themes that underpin HCPs’ experience
of prescribing opioids to patients with chronic non-
malignant pain. A core concept overarching all six
themes was a sense of ambiguity surrounding opioid
prescribing.
Confidence in review findings (GRADE -CERQual
assessment)
Indicators of confidence in our review findings as rec-
ommended in the GRADE -CERQual framework [32]
are shown in Table 3. Both reviewers rated all studies as
satisfactory. Twelve studies were directly relevant and
aimed to explore the experience of opioid prescription
[33–35, 37–39, 41, 43, 44, 46, 48, 49]. The remaining
Fig. 1 Flow Chart showing results of systematic search: this figure give the records identified, screened, retrieved, appraised and included in
the review
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five studies were partially relevant and included themes
related to opioid prescription. Table 3 shows the number
of concepts and the number of studies out of 17 sup-
porting each review finding. We rated our confidence in
the review finding as high when it was supported by
more than half of the studies. However, there is cur-
rently no agreed way of making an assessment of confi-
dence for qualitative synthesis.
Thematic analysis
Our synthesis supports six themes that can help to under-
stand HCPs experience of prescribing opioids to patients
with chronic non-malignant pain: (1) Should I, shouldn’t
I? (2) Pain is Pain; (3) Walking a fine line; (4) Social guard-
ianship; (5) Moral boundary work; (6) Regulations and
guidelines. We have illustrated each theme with examples
of narrative from the primary studies.
Should I, shouldn’t I?
The theme ‘should I, shouldn’t I?’ describes the sense of
uncertainty about when to prescribe opioids, and a feel-
ing of ambiguity about the effects of medication. This
feeling was heightened by an observation that, in similar
circumstances, other HCPs seemed to make different
clinical decisions:
When we’re practicing alongside other people who
have come to completely different conclusions, it
really makes you think … have I been making the
wrong decisions; did we get different information
and come to different conclusions? Do we have
different values that underlie our decision-making?
[35] (physician, USA)
HPCs found it harder to approach analgesic prescribing
where the disease aetiology was unknown, for example,
in fibromyalgia.
Because you don’t really know what’s happening there.
The aetiology of the disease is not really known and
you have few means of knowing what you’re doing.
You’re treating the pain and you don’t know why
there is no response [36] (rheumatologist, Spain)
They are in pain, you give them something for the
pain and: ‘it doesn’t do me any good … it relieved the
pain a little but the pain has come back’ … . No
matter what you give them, the pain doesn’t go away
[36] (GP, Spain)
There was a sense that clinical education did not prepare
HCPs adequately for these decisions.
We took an advanced pharm[acology] class, and we
discussed it in one lecture, but that was it. Isn't that
ridiculous considering how many people we see in
pain? [38] (practise nurse, USA)
Uncertainty was also compounded by the sense that spe-
cialist referrals were either restricted or unproductive.
Some HCPs felt unsupported in managing the most dif-
ficult cases and explored the possibility of more special-
ist services: for example, for patients with chronic pain
and substance abuse:
Often I find that they are not accomplishing any more
than I was and [patients] are often sent back to me
with them [pain specialists] essentially saying, ‘we did
our best.’ It’s very frustrating, because if they were
easy patients they wouldn’t have been seeing them …
they wouldn’t have been referred … I would love for
there to be a separate clinic where I could refer
patients for management of their chronic pain and
substance abuse simultaneously. Kind of take me out
of the picture [34] (physician, USA)
Table 3 Confidence in review findings – GRADE -CERQual assessment
REVIEW FINDING METHODOLOGICAL
LIMITATIONS (NUMBER
OF SATISFACTORY STUDIES)
RELEVANCE
(PARTIAL OR
DIRECT)
ADEQUACY
(NUMBER OF
CONCEPTS)
COHERENCE* (NUMBER
OF STUDIES OUT OF 17)
OVERALL ASSESSMENT
OF CONFIDENCE
SHOULD I, SHOULDN’T I? ALL 9 DIRECT 19 9 [34–39, 43, 44, 48] HIGH CONFIDENCE
PAIN IS PAIN ALL 5 DIRECT,
1 PARTIAL
8 6 [33, 39, 40, 42, 46, 48] MODERATE CONFIDENCE
WALKING A FINE LINE ALL 9 DIRECT,
1 PARTIAL
16 8 [33, 35, 39–41, 45, 46, 48] MODERATE CONFIDENCE
SOCIAL GUARDIANSHIP ALL 10 DIRECT,
1 PARTIAL
17 11 [33–35, 37–39, 41, 43, 45, 46, 48] HIGH CONFIDENCE
MORAL BOUNDARY WORK ALL 12 DIRECT,
2 PARTIAL
27 14 [33–35, 37–39, 41, 43–49] HIGH CONFIDENCE
REGULATIONS AND
GUIDELINES
ALL 8 DIRECT 18 8 [34, 35, 38, 39, 41, 43, 48, 49] MODERATE CONFIDENCE
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Pain is pain
The theme ‘pain is pain’ is underpinned by the ideal that
if a person is in pain then the primary aim of the HCP
should be to relieve pain. Some felt that even addiction
should not be a barrier to opioid prescription and described
the stigma against patients with addiction:
I had a guy last week who'd been stabbed and he'd
been in ITU … and he had to discharge himself
because they wouldn't give him any pain control … he
wasn't even getting his prescribed dose of methadone
he was getting under dosed for his addiction and his
pain control … there's a protocol … but they choose
not to know about it and it's just pure stigma. [33]
(physician, UK)
At the end of the day, if someone’s got chronic pain it
doesn’t matter if they’re addicted to painkillers if it
sorts out their quality of life [39] (GP, UK)
However, although in theory ‘pain is pain’, HCPs described
factors that would make them less likely to prescribe
opioids in practice for chronic non-malignant pain. For
example, whereas for malignant pain the aim might be to
achieve complete pain relief, in non-malignant pain the
HPC would need to consider the balance of risks and
benefits of long term opioid prescription over time:
I don’t regard them [malignant and non-malignant
pain] the same … with [malignant pain] … your aim
always is to get complete relief of pain … over a finite
period of time. For chronic pain … you’ve got to
weigh up … the potential side effects… I think there
has to be an acceptance that you are not necessarily
going to get them pain free because they’ve got the
rest of their lives to live as well … so your two end
points are different [46] (GP, UK)
Some HCPs queried whether enough attention was given
to chronic non-malignant pain when the focus was mainly
on pain control in palliative patients.
The only people in my practice that I prescribe [opioids]
to would be people who are palliative … . [on the other
hand] we tend to focus too much on pain control for
palliation as opposed to just everyday clients. Certainly
nobody wants to die in pain, but nobody wants to live in
pain either [40] (physician, Canada)
Walking a fine line
The theme ‘walking a fine line’ describes the need for HCPs
to carefully balance the benefits and adverse effects of opi-
oids. On the one hand, emphasising adverse effects might
lead to unnecessary pain; on the other hand, emphasis on
pain control might lead to harm or abuse. Some HCPs felt
that treating pain should take priority over the risk of
opioid misuse when making prescribing decisions.
I mean there are two mistakes you make. You can
make the mistake of under treating or of giving
medicines that end up being sold or used for
unintended purposes. You’re going to make errors
both ways, and I think it’s generally better to risk
opiates being misused versus not treating someone’s
pain [35] (physician, USA)
There were additional concerns about prescribing opioids
to older adults because of the potential severity and impact
of adverse effects. In theory a person’s age should not affect
decisions, but in practise, there was a sense that it does.
But there are safety issues, and at the end of the day if
they came to grief and fell over, fell down the stairs
and broke something, died, then, you know, you’d feel
guilty about giving them adequate pain relief in your
view, but excessive side effects, drowsiness, what have
you, that contributed to some major event on their
part. So we walk at a fine line sometimes between
giving adequate pain relief and giving safe treatment
[39] (GP, UK)
Although HCPs felt that opioids should be used to manage
older peoples’ pain, they also discussed how the risks and
benefits of prescribing opioids would require assessment on
an individual basis.
Older people metabolize medication differently than
younger people, so you don’t want to give them
medication that’s going to impair their ability to
function … A lot of them drive even though they may
be even much older, so you don’t want falls. You don’t
want automobile accidents. You don’t want injuries.
You don’t want to interfere with their ability to make
judgments and so on, so I don’t like using opioids in
elderly people at all … [however] my feeling is that
they should be used, but we need to, again, look at
each person individually, and then determine which
person benefits from opioid therapy [45] (HPC not
stated, USA)
Social guardianship
The theme ‘social guardianship’ describes a culture hostile
to opioid use and the professional taboo of prescribing
opioids. HCPs compared their own prescribing practise to
their colleagues and were concerned over being judged by
their peers. Some felt that they had a personal responsibil-
ity to protect society from the consequences of opioid
misuse and viewed patients with suspicion, particularly if
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they requested opioids. To protect society, some imple-
mented strategies to control patients’ behaviour (for
example: bottle checks, opioid contracts, background
checks). HCPs also described concerns over diversion
of opioid prescriptions to others.
I am a naysayer on opiates … too much of my day is
spent policing how many [opioids] have been prescribed
and how many times a patient is a return patient and
how often they visited requesting opiate prescriptions
[41] (emergency physician, USA)
If you prescribe to a population where you think
diversion is going on, you definitely have a
responsibility. I also worry about who is getting the
drug, is it my son? I mean, we are members of society
after all… . I think it is okay to go into a relationship
with some mistrust. It is survival in the business we
are in [38] (advanced practice nurse, USA)
Some HCPs discussed indicators of potential abuse (for
example: lost prescriptions, early requests for medication,
frequent attendance), although acknowledged that these
might actually indicate poorly managed pain.
If people are taking it genuinely for pain they tend
to stick to the prescribed dosage … addicts tend to
be the ones who are always ordering early … you
don't lose your tablets if you are … getting great
benefit from them for pain [33] (physician, UK)
The concern would be is this pain real, or is it just
put on to obtain opioid? … I mean, an assessment of
the pain and whether I think it’s genuine or not. I
think it’s very difficult; it’s something I’m currently
dealing with at the moment, and not very successfully
[46] (GP, UK)
Moral boundary work
The theme moral boundary work is underpinned by the
clinical work of deciding whose pain is ‘real’ and thus
who should be prescribed opioids. HCPs described ideal
patients (for example, those that made appropriate
demands, took advice and did not cause trouble) and
‘difficult’ patients (the demanding, non-adherent and
trouble-making). They made judgments based on non-
clinical factors about whether or not a patient was
‘legitimate’.
For those patients that have a legitimate reason for
wanting to take it and if I can trust them—that they
are not selling, they’re not abusing, and most of
these are older patients of mine. They never request
early refills, they don’t go to the [emergency room]
in between visits to get them—there’s no need for me
to do periodic drug screenings and so forth (primary
care physician, USA) [43]
Pain with no biomedical diagnosis, vague symptoms or
dissonance between a patient’s report of pain and profes-
sional observation could trigger suspicion.
A lot of patients you can tell … that they really need it
… based on their underlying pathology, for example, a
patient who has a cancer or a real anatomic foundation
for it … now this is not 100% reliable, but you have to
count on more observation, combined with other
clinical data. So after 2 or 3 visits, you pretty much
know who is abusing and who is not [43] (primary care
physician, USA)
I think for patients who have chronic pain it’s more
challenging and I think that’s the place where I’m
constantly rethinking my practice… You’re always on
the fence: am I doing the right thing for my patient?
[41] (Emergency physician, USA)
Non-clinical moral judgments or gut-feelings contributed
to prescribing decisions. HCPs recalled episodes when
they had made a mistake by trusting ‘the wrong’ patient.
Over time they described how they had become better at
making the right decision.
The way I behave now prescribing for everything is a
sort of rather woolly, nebulous product of everything
I’ve done… You just pick it up over the years, so I’m
sure I’ve been moulded by the successes and the failures
which have come my way … we all learn on the hoof,
don’t we?’ … I think everybody’s fingers get burnt with
people who you give the opioids to with a more trusting
attitude than maybe you should have [46] (GP, UK)
I’ve had trust in people, and it’s been betrayed … I find
I’m not always that great a judge of who to trust and
who not to trust… . I think people feel like they’ve been
violated, you know, cheated, like they’ve been taken
advantage of. I feel some of that, too. Ultimately you
feel you’ve made a poor judgment, and you get mad at
yourself … My impression was that he had a true ankle
problem. Then you find out it was all lies … you’re
allowed to make mistakes [35] (physician, USA)
However, some sensed the dangers of judging a book by
its cover and acknowledged that basing clinical decisions
on their gut feeling was not fair or accurate.
There’s a disconnect … even if it’s the sweetest little
85-year-old woman who looks like your grandmother,
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versus, you know, some guy from the ghetto wearing
his pants down at his knees … it shouldn’t really
matter [49] (physicians, USA)
Regulations and guidelines
The theme regulations and guidelines depict HCPs’ views
about external regulation of opioid prescription (specific-
ally guidelines, opioid agreements and drug screening).
Some described a negative view of prescribing guidelines
and felt that they interfered with professional autonomy;
an example of the ‘legislature practising medicine without
a licence’ [41].
You’re there to help them and they can tell you their
deepest, darkest secrets, but yet you’re policing
them… . I’m not a big drug screen person, to be
honest, because I like to see the person as a person.
I’m not clouded by all this other stuff … You can’t do
your job when you are thinking about these things
[43] (primary care physician, USA)
There could be negative implications to that if patients
are actually leaving the emergency department because
of the way they interpret that [regulations] poster …
there’s potential that sick patients could actually leave
your emergency department when they need help [41]
(emergency physician, USA)
HCPs described fears legislative reprimand.
My name is on that bottle. If they lose it and someone
else takes it and they die, who do you think they are
going to come to? What if it is a kid who takes it just
for fun—my name is on that, not yours. … I had a
patient die. He took the entire bottle, and the police
came to see me because they found him dead with the
empty bottle with my name on it, and I say to patients
now, ‘I am only going to give you a small amount,
because I don't want you found dead with my name on
your bottle.’ [38] (Advanced practice nurse, USA)
Others described a negative view of opioid prescribing
agreements and drug screening as striking a blow at the
heart of a patient-clinician relationship by creating mistrust
and hostility.
It can really strike a major blow to trust in the doctor
patient relationship when you ask someone to sign a
piece of paper … A huge power play on the part of
the doctor … if there is already mistrust between the
patient and the doctor, it could heighten that mistrust
… .It takes work on the provider’s part, to make it an
alliance-building instrument instead of a punitive
contract [49] (physician, USA)
Some HPCs described a more positive attitude to regula-
tion. For example, opioid agreements could be useful in
establishing boundaries and opening up honest discussion.
I think it improves the care, because you are able to
then have more open and frank discussions around
their pain … . and [about] other things going on in
their life … In the best of circumstances it actually
will make for a deeper more trusting relationship [49]
(physician, USA)
Some used guidelines as leverage or to justify decisions
and thus help them to deal with ‘challenging’ patients.
I tell them this is standard protocol. I’m not singling
you out. I’m not picking on you. I’m not treating you
like an addict. This would happen to anybody. If you
take our chronic pain meds long enough, anybody will
become physically dependent on them [43] (primary
care physician, USA)
[An agreement] gives me leverage or comfort in
discontinuing the medication if the patient violates
the agreement, because we’ve kind of laid it out from
the beginning that those behaviors were not okay… .
it made my life a little easier, but I’m not sure it did
the patients a giant service [49] (physician, USA)
Summary and conceptual framework
We developed six themes that help us to understand
HCPs experience of prescribing opioids to patients with
chronic non-malignant pain:
‘Should I, shouldn’t I?’ demonstrates feelings of ambiguity
about describing opioids for chronic non-malignant pain;
‘Pain is pain’ demonstrates that although the ideal aim is
to alleviate pain, in practice there are reasons why a HCP
might not prescribe opioids to people with chronic non-
malignant pain; ‘Walking a fine line’ describes the need to
balance the benefits and adverse effects of opioids; ‘Social
guardianship’ describes a culture hostile to opioid use
and a feeling of personal responsibility to police and
protect society; ‘Moral boundary work’ describes the
work of deciding whose pain is ‘real’; ‘Regulations and
guidelines’ describes ambivalence towards external
regulation and guidelines.
Our conceptual model hinges on the HCPs need to
decipher the ambiguity surrounding opioid prescription
for chronic non-malignant pain and (Should I, shouldn’t
I?) (Fig. 2). Social suspicion and hostility toward opioids
(social guardianship) will tip the balance for prescribing
towards the negative, whereas the pre-eminence of pain
(pain is pain) might tip the balance toward prescribing.
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The decision is not clear-cut. Firstly, HCPs might make
non-clinical judgments about the person (moral boundary
work), thirdly, they must determine the balance of positive
and adverse effects for each individual (walking a fine line)
and finally there is a sense of professional ambivalence
towards prescribing guidelines (regulations and guide-
lines). This conceptual model demonstrates the complex-
ity of making a decision to prescribe opioids to someone
with non-malignant pain. It also demonstrates that the
decision is influenced by intra- and interpersonal factors
and broader external concerns.
Discussion
This exploration of HCPs experience of prescribing opioids
is embedded within a wider qualitative evidence synthesis
that aims to further understand healthcare professionals’
experience of treating patients with chronic non-malignant
pain [20]. The findings of qualitative research are an inter-
pretation of data. The centrality of interpretation to qualita-
tive research is also its strength; it aims to challenge and
develop ideas rather than test theories. In collaborative pro-
jects individual interpretations enter into a dialectic process
where they are challenged and modified. Our model is
based on a rigorous collaborative process that included
the research team and an advisory group that included
patients and clinicians. The innovation of our study is
to identify concepts that explore HCPs’ experience of
prescribing opioids and to provide a conceptual framework
to help us to understand its complexity. This topic is im-
portant because an increasing number of HCPs are pre-
scribing opioids despite very limited evidence for long-term
opioid therapy for chronic non-malignant pain outside
of end-of-life care [18]. In light of recent USA Guide-
lines [11] and UK [12] resources, our conceptual model
can help us to try and unpick why HCPs prescribe opioids
for chronic non-malignant pain. Understanding that this
process is complex and that guidelines are only one aspect
of the process can help suggest how we can address changes
to opioid prescribing. Ten out of the 17 studies explored
experiences in the USA where the recently introduced bill
to congress on opioid abuse prevention and treatment sug-
gests a move towards tighter controls (https://www.congress
.gov/bill/115th-congress/house-bill/993/text). Their guide-
lines [11] conclude “evidence on long-term opioid therapy
for chronic pain outside of end-of-life care remains limited,
with insufficient evidence to determine long-term benefits
versus no opioid therapy … and extensive evidence shows
the possible harms of opioids”. Similarly, a UK resource to
support the prescribing of opioids [12] stated “there is little
evidence that they [opioids] are helpful for long term pain.”
There is thus a drive to move away from prescribing opioids
for chronic non-malignant pain.
Our conceptual model demonstrates that opioid pre-
scription is underpinned by the therapeutic aim of allevi-
ating pain. HCPs reported a professional duty to get rid
of pain (‘pain is pain’). However, recent guidelines are
clear that patients who do not achieve useful pain relief
from opioids within 2–4 weeks are unlikely to gain benefit
in the long term [11, 12]. It might be anticipated that re-
ported inefficacy of opioids for chronic non-malignant pain
would be a significant reason for not prescribing. However,
our findings do not indicate that the limited efficacy of opi-
oids for chronic non-malignant pain is a barrier to prescrib-
ing. This has clear implications for education, policy and
practice. That professionals expressed the importance of
alleviating pain suggests the necessity of an intervention
that discontinues opioids if they show no benefit. A study is
underway in the UK that is testing an intervention to
Fig. 2 Conceptual framework: this figure illustrates the conceptual framework that demonstrates the complex decision ‘Should I shouldn’t I?’
prescribe opioids for chronic non-malignant pain. The decision is underpinned by the need to decipher ambiguity. ‘Social guardianship’ tips the
balance against a decision to prescribe, whereas a sense that ‘pain is pain’ tips the balance towards prescribing. However the decision is not
straightforward. The influence of the themes, ‘moral boundary work’, ‘walking a fine line’ and ‘regulations and guidelines’ are not clear-cut and
add complexity to the decision
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reduce opioid use and provide other support for people
with chronic non-malignant pain. The primary studies in
this review were published between 2007 and 2015, thus
pre-dating the recent guidelines [11, 12]. It is therefore im-
portant to consider any potential delay, inherent in system-
atic reviews, between publication and impact on practice.
Findings demonstrate that although some HCPs were
aware of the adverse effects of opioids (‘walking a fine
line’), they remained concerned that deciding not to pre-
scribe would lead to unnecessary suffering. In addition,
although HCPs discuss potential harm from opioids, the
focus was on preventing abuse and addiction. It could
be argued that the elephant in the room is the increasing
death rate from opioid-related prescription [50, 51].
Between 2003 and 2013, the age-adjusted drug poison-
ing death rate involving opioid analgesics in the USA
increased from 2.9 to 5.1 deaths per 100,000 population
[51]. In a Canadian study (1997–201), 1.8% of those pre-
scribed opioids escalated to high dose therapy and 2% died
of opioid-related causes while on treatment [50]. Our
findings also support a feeling of ambiguity about the
efficacy of opioid medication for people with chronic
non-malignant pain (‘Should I, shouldn’t I?’), which in-
dicates a gap in knowledge to be filled.
We found that a strong antagonist for prescribing opioids
was a feeling of personal responsibility to police and protect
society from opioid misuse (‘social guardianship’). This was
aligned with the ‘Moral boundary work’ of determining
who had ‘real’ pain and who might potentially be playing
the system. A qualitative evidence synthesis of patients’ ex-
perience of living with chronic non-malignant pain [21] has
shown they struggle to prove their legitimacy and experi-
ence their pain as adversarial and contested; patients with
chronic non-malignant pain often experience the shame
and stigma of not fitting the medical model and struggle to
prove their credibility to others [21]. An environment of
mistrust and suspicion is likely to add to this negative ex-
perience of healthcare. A more positive and collaborative
frame for making the decision to prescribe, or not, might
be useful. For example, emphasising the limited efficacy
and serious adverse effects of opioids [11, 12].
Finally, our findings demonstrate ambivalence towards
the external regulation of opioid prescription. There was
a sense that regulation limited professional autonomy
and that there should be freedom to prescribe. Some felt
that regulation could lead to mistrust and hostility. Others
felt that opioid agreements could help to open up honest
discussion. Others used them to justify difficult or un-
popular decisions. Our search strategy focused generically
on chronic non-malignant pain. Further research might
usefully focus on specific diagnoses, such as osteoarthritis
or rheumatoid arthritis, in order to explore potential simi-
larities and difference in HCP experience of treating these
conditions.
Conclusion
The innovation of this study is to provide a synthesis of
qualitative research that helps to explain the challenges
involved with prescribing opioids to patients with chronic
non-malignant pain. We demonstrate that syntheses of
qualitative research can help us to understand complex
processes of care and for the first time uncover a new
overarching concept of “ambiguity” that explains the bal-
ancing required around many of the factors HCPs take
into account when prescribing opioids for chronic non-
malignant pain. Our findings can inform HCPs dealing
with these difficult decisions. Findings demonstrate that
the decision is influenced by intra- and interpersonal fac-
tors and broader external concerns. Although opioid pre-
scription is underpinned by the therapeutic aim of
alleviating pain, this aim may be misplaced. In view of the
rise of opioid prescription and recent guidance, further re-
search to explore HCPs’ experience and view of guidelines
would be useful. Research to explore patients’ experience
of deciding to take opioids for chronic non-malignant pain
is also timely. This would help us to understand the moti-
vations and experiences of those with chronic non-
malignant pain, and the HCPs trying to manage that pain.
Acknowledgements
Thanks to the authors of the qualitative studies included in the meta-ethnography
and all the healthcare professionals who shared their stories. Thanks also to our
project advisory group of patients and healthcare professionals.
Funding
This study was funded by the National Institute for Health Research Health
Services and Delivery Research Programme 14/198/07. The views and opinions
expressed therein are those of the authors and do not necessarily reflect those
of the HS&DR Programme, NIHR, NHS or the Department of Health.
Availability of data and materials
The original study protocol can be found at: https://www.journalslibrary.nihr.ac.uk/
programmes/hsdr/1419807#/ and is being published as a full monograph with
supporting supplementary data.
Authors’ contributions
I would like to confirm that all authors have read and approved the final
manuscript. FT, KB and KS made a substantial contribution to the design,
acquisition, analysis and interpretation of data. ST made a substantial
contribution to the analysis and interpretation of data. FT drafted the first,
subsequent and final versions. KS, KB and ST revised all versions for
important intellectual content and approved the final version. All authors
agree to be accountable for the accuracy and integrity of the work.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Toye et al. BMC Family Practice  (2017) 18:94 Page 12 of 13
Author details
1Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation
Trust, Windmill Road, Oxford 0X3 7HE, UK. 2Warwick Research in Nursing,
Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
3Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal
Sciences (NDORMS), University of Oxford, Windmill Road, Oxford 0X3 7LD,
UK.
Received: 26 June 2017 Accepted: 15 November 2017
References
1. Breivika H, et al. Survey of chronic pain in Europe: prevalence, impact on
daily life, and treatment. Eur J Pain. 2006;10(4):287–333.
2. Elliott AM, et al. The epidemiology of chronic pain in the community.
Lancet. 1999;354:1248–52.
3. König HH, et al. Comparison of population health status in six European
countries: results of a representative survey using the EQ-5D questionnaire.
Med Care. 2009;47:255–61.
4. Covinsky KE, Lindquist K, Dunlop DD, Yelin E. Pain, functional limitations,
and aging. J Am Geriatr Soc. 2009;57:1556–61.
5. Croft P, Peat G, Van-der-Windt D. Primary care research and musculoskeletal
medicine. Primary Health Care Res Dev. 2010;11:4–16.
6. Smith B, et al. The impact of chronic pain in the community. Fam Pract.
2001;18:292–9.
7. Department-of-Health, Pain breaking through the barrier. Chief Medical
Officer’s report, 2009. 150th annual report of the Chief Medical Officer.
8. Toye F, Jenkins S. ‘It makes you think’ – exploring the impact of qualitative
films on pain clinicians. Br J Pain. 2015;9(1):65–9.
9. Parsons S, et al. The influence of patients' and primary care practitioners'
beliefs and expectations about chronic musculoskeletal pain on the process of
care: a systematic review of qualitative studies. Clin J Pain. 2007;23(1):91–9.
10. Breen A, et al. "you feel so hopeless": a qualitative study of GP management
of acute back pain. Eur J Pain. 2007;11(1):21–9.
11. Dowell D, TM. Haegerich, and R. Chou, CDC (Centers for Disease Control
and Prevention) Guideline for Prescribing Opioids for Chronic Pain — United
States, 2016. Morb. Mortal. Wkly. Rep, 2016. Report 65, March 15: p. 1–49.
12. Royal-College-of-Anaesthetists, Opioids Aware: A resource for patients and
healthcare professionals to support prescribing of opioid medicines for
pain. 2016(8th November 2016).
13. Ruscitto A, Smith BH, Guthrie B. Changes in opioid and other analgesic use
1995–2010: repeated cross-sectional analysis of dispensed prescribing for a
large geographical population in Scotland. Eur J Pain. 2015;19:59–66.
14. Zin CS, Chen L-C, Knaggs RD. Changes in trends and pattern of strong
opioid prescribing in primary care. Eur J Pain. 2014;18:1343–51.
15. Levy B, et al. Trends in opioid analgesic-prescribing rates by specialty, U.S.,
2007–2012. Am J Prev Med. 2015;49:409–4013.
16. Paulozzi LJ, Mack KA, Hockenberry JM. Vital signs: variation among states in
prescribing of opioid pain relievers and benzodiazepines—United States,
2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):563–8.
17. Fredheim O, et al. Prescription pattern of codeine for non-malignant pain: a
pharmacoepidemiological study from the Norwegian prescription database.
Acta Anaesthesiol Scand. 2009;53(5):627–33.
18. Chou R, et al. The Effectiveness and Risks of Long-Term Opioid Treatment of
Chronic Pain. The Evidence Report/Technology Assessment, Number 218,
2014. Prepared by the Pacific Northwest Evidence-based Practice Center
under Contract No. 290–2012-00014-I (Agency for Healthcare Research and
Quality (AHRQ) Publication No. 14-E005-EF). https://effectivehealthcare.ahrq.
gov/topics/chronic-pain-opioid-treatment/research/.
19. Daubresse M, et al. Ambulatory diagnosis and treatment of nonmalignant
pain in the United States, 2000-2010. Med Care. 2013;51:870–8.
20. Toye F, Seers K, Barker K. 2015–17. www.journalslibrary.nihr.ac.uk/
programmes/hsdr/1419807/#/.
21. Toye F, et al. A meta-ethnography of patients' experiences of chronic non-
malignant musculoskeletal pain. Health Services and Delivery Res. 2013;
1(12):1–189.
22. Noblit G, Hare R. Meta-ethnography: Synthesising Qualitative Studies.
Qualitative research methods series 11. 1988. California: Sage Publications.
23. Wong SS, Wilczynski NL, Haynes RB. Developing optimal search strategies
for detecting clinically relevant qualitative studies in MEDLINE. Medinfo.
2004;11(1):311–6.
24. Wilczynski NL, Marks S, Haynes RB. Search strategies for identifying
qualitative studies in CINAHL. Qual Health Res. 2007;17(5):705–10.
25. McKibbon KA, Wilczynski NL, Haynes RB. Developing optimal search
strategies for retrieving qualitative studies in PsycINFO. Eval Health Prof.
2006;29(4):440–54.
26. Walters LA, Wilczynski NL, Haynes RB. Hedges team., Developing optimal
search strategies for retrieving clinically relevant qualitative studies in
EMBASE. Qual Health Res. 2006;16(1):162–8.
27. Toye F, et al. Meta-ethnography 25 years on: challenges and insights for
synthesising a large number of qualitative studies. BMC Med Res Methodol.
2014:14(80).
28. Campbell R, et al. Evaluating meta-ethnography: systematic analysis and
synthesis of qualitative research. Health Technol Assess. 2011;15(43)
29. Dixon-Woods M, et al. Appraising qualitative research for inclusion in
systematic reviews: a quantitative and qualitative comparison of three
methods. J Health Serv Res Policy. 2007;12(1):42–7.
30. CASP. Critical Appraisal Skills Programme: making sense of evidence about
clinical effectiveness: 10 questions to help you make sense of qualitative
research. 2010. http://www.casp-uk.net/casp-tools-checklists.
31. Toye F, et al. Trying to pin down jelly' - exploring intuitive processes in quality
assessment for meta-ethnography. BMC Med Res Methodol. 2013;13:46.
32. Lewin S, et al. Using qualitative evidence in decision making for health and
social interventions: an approach to assess confidence in findings from
qualitative evidence syntheses (GRADE-CERQual). PLoS Med. 2016;12(10):
e1001895. doi:10.1371/journal. pmed.1001895.
33. Baldacchino A, et al. Guilty until proven innocent: a qualitative study of the
management of chronic non-cancer pain among patients with a history of
substance abuse. Addict Behav. 2010;35(3):270–2.
34. Barry T, et al. Opioids, chronic pain, and addiction in primary care. J Pain.
2010;11(12):1442.
35. Berg M, et al. Providers' experiences treating chronic pain among opioid-
dependent drug users. J Gen Intern Med. 2009;24(4):482.
36. Briones-Vozmediano E, et al. Patients' and professionals' views on managing
fibromyalgia. Pain Res Manag. 2013;18(1):19–24.
37. Esquibel AY, Borkan J. Doctors and patients in pain: conflict and collaboration
in opioid prescription in primary care. Pain. 2014;155(12):2575–82.
38. Fontana JS. The social and political forces affecting prescribing practices for
chronic pain. J Prof Nurs. 2008;24(1):30–6.
39. Gooberman-Hill R, et al. Professional experience guides opioid prescribing
for chronic joint pain in primary care. Fam Pract. 2011;28(1):102.
40. Kaasalainen S, et al. Pain management decision making among long-term
care physicians and nurses. West J Nurs Res. 2007;29(5):561.
41. Kilaru S, et al. How do physicians adopt and apply opioid prescription
guidelines in the emergency department? A qualitative study. Ann Emerg
Med. 2014;64(5):482.
42. Kaasalainen S, et al. An action-based approach to improving pain
management in long-term care. Can J Aging. 2010;29(4):503–18.
43. Krebs E, et al. Barriers to guideline-concordant opioid management in
primary care—a qualitative study. J Pain. 2014;15(11):1148.
44. McCrorie C, et al. Understanding long-term opioid prescribing for non-
cancer pain in primary care: a qualitative study. BMC Fam Pract. 2015;16:121.
45. Ruiz JG, et al. Primary care management of chronic nonmalignant pain in
veterans: a qualitative study. Educ Gerontol. 2010;36(5):372–94.
46. Seamark D, et al. GPs prescribing of strong opioid drugs for patients with
chronic non-cancer pain: a qualitative study. Br J Gen Pract. 2013;63(617)
47. Siedlecki L, et al. Exploring how bedside nurses care for patients with
chronic pain: a grounded theory study. Pain Manag Nurs. 2014;15(3):565.
48. Spitz A, et al. Primary care providers' perspective on prescribing opioids to
older adults with chronic non-cancer pain: a qualitative study. BMC Geriatr.
2011;11:35.
49. Starrels L, et al. It made my life a little easier: primary care providers' beliefs
and attitudes about using opioid treatment agreements. J Opioid Manag.
2014;10(2):95.
50. Kaplovitch E, et al. Sex differences in dose escalation and overdose death
during chronic opioid therapy: a population-based cohort study. PLoS One.
2015;10(8):e0134550. doi:10.1371/journal.pone.0134550.
51. National-Center-for-Health-Statistics, Health, United States, 2014: With
Special Feature on Adults Aged 55–64. Hyattsville: 2015.
Toye et al. BMC Family Practice  (2017) 18:94 Page 13 of 13
